William Holmes, MD
Dermatology · Henderson, NVNPI 1518195155
Payments from drug & device makers
Across 19 payments — averaging $28.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$157
- Sanofi$125
- Lilly USA, LLC$66
- LEO Pharma Inc.$46
- Solta Medical, A Division Of Bausch Health US, LLC$26
- Galderma Laboratories, L.p.$21
- plus $95 from 5 others
What the payments were for
- Food & beverage$536100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 7 | $157 |
| Sanofi | 1 | $125 |
| Lilly USA, LLC | 2 | $66 |
| LEO Pharma Inc. | 2 | $46 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $26 |
| Galderma Laboratories, L.p. | 1 | $21 |
| Verrica Pharmaceuticals Inc. | 1 | $20 |
| UCB, Inc. | 1 | $20 |
| Johnson & Johnson | 1 | $19 |
| Krystal Biotech Inc | 1 | $19 |
| Biofrontera Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$125
How this compares
$536 in reported general payments places this provider in the 15th percentile of 78 dermatology providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gentamicin Sulfate | 101 | $3,610 |
| Mupirocin | 230 | $1,254 |
| Fluorouracil | 17 | $1,131 |
| Imiquimod | 15 | $388 |
| Cephalexin | 39 | $82 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 17 | $39 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Henderson
- Curt SamlaskaHenderson$101K
- Robert LiebermanHenderson$26K
- Juian-Juian FuHenderson$12K
- Cristian GonzalezHenderson$3K
- Daniel XieHenderson$2K
- Harry GreenbergLas Vegas$1.5M
- David CotterLas Vegas$1.5M
- Victoria FarleyLas Vegas$956K
- Miriam BettencourtLas Vegas$772K
- James SolomonNorth Las Vegas$733K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.